International Linked Clinical Trials (iLCT)

2 results.

February 7, 2025 After the recent exenatide results, what’s next in Parkinson’s disease research and clinical trials?

Earlier this week, The Lancet published results of a phase 3 clinical trial that explored whether the Type 2 diabetes medication exenatide could…

January 10, 2023 Cough medicine offers hope of new treatment to slow the progression of Parkinson’s disease

London, United Kingdom (Jan. 10, 2023) — Following promising results reported at Phase 2 in 2020, a large-scale Phase 3 clinical trial of ambroxol,…